Article
Gastrointestinal stromal tumor and its targeted therapeutics.
Chinese journal of cancer - 1 May 2011
Dupart Jheri, Zhang Wei, Trent Jonathan C
Abstract excerpt
Over the past 60 years, investigators of basic science, pathology, and clinical medicine have studied gastrointestinal stromal tumor (GIST) and made minor advances in patient care. Recent discoveries have led to an understanding of the biological role of KIT and platelet-derived growth factor receptor-α in GIST and the development of the tyrosine kinase inhibitor imatinib mesylate (Gleevec, formerly STI-571), one...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
